KẾT QUẢ PHẪU THUẬT NỘI SOI CẮT BÁN PHẦN XA DẠ DÀY ĐIỀU TRỊ UNG THƯ DẠ DÀY

Abstract

Objectives: Evaluation of early results of totally laparoscopic distal gastrectomy (TLDG) with D2 lymph node dissection treatment gastric cancer from 1/2019 to 8/2020 at Digestive Surgery Department, 108 Military Central Hospital. Patients and methods: A prospective descriptive study on 108 patients gastric cancer underwent TLDG with D2 lymph node dissection. Result: Mean age was 59.5 ± 12.1 (youngest patient was only 25 and the oldest was 86). Mean BMI was 21.0 ± 2.3 kg/m². 14.8% patients were T1a; 18.5% patients were T1b; 16.7% patients were T2; 23.1% patients were T3 and 24.1% patients were T4a in terms of depth of invasion. Number of haversted lymph nodes in average was 27.2 ± 10.4  (range 7 - 61). 100% of the proximal and distal sections have no cancer cells. There were no case transfering to open surgery. Mean operative time was 159.9 ± 44.6  (range 72 - 333) minutes. Mean time to first flatus was  3.7 ± 3.3  (range 1 - 35) days. Mean postoperative hospital stay was 8.7 ± 4.1 (range 5 - 44) days. Early postoperative complication rates were 5.6% including 02 case of gastroenteric fistula, 04 cases of early intestinal obstruction. All were treated conservatively without operation. There were no cases of duodenal fistula, abdominal bleeding, anastomosis, fluid collection, abdominal abscess, pancreatic fistula, surgical site infection, and postoperative mortality. Conclusion: Totally laparoscopic distal gastrectomy with  D2 lymph node dissection is safely and feasibly in the treatment of gastric cancer.